Brief Behavioural Economic Intervention for Smoking Cessation (QTW2024)

July 17, 2024 updated by: Tzu Tsun Luk, The University of Hong Kong

Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2024: a Randomised Controlled Trial of a Brief Behavioural Economic Intervention

The goal of this clinical trial is to test the effectiveness of brief behavioural economic intervention in promoting smoking cessation among smokers in the community.

Study Overview

Detailed Description

Smoking cessation services are free and effective but underused in Hong Kong. Active referral to smoking cessation services has consistently been found effective in promoting service use and successful quitting as a stand-alone strategy or when combined with other interventions. Participants who received active referral are introduced about the cessation services in Hong Kong and offered connection to the services of their choices. Contacts of participants who agreed to be referred are transferred to the selected cessation providers, who will subsequently contact the participants for further treatment.

The current active referral intervention uses an opt-in approach, where participants are required to actively choose to be connected to the services. By leveraging behavioural economic principles, a simple yet promising strategy to strengthen the active referral intervention is to utilize an "opt-out" approach, where participants are automatically referred to the service unless they actively decline the referral. By making referral to smoking cessation services as the default choice, the investigators aim to increase the uptake of these services and thus improve smoking cessation outcomes. Additionally, mobile messaging informed by behavioural economics principles can serve as nudges to prompt smokers to initiate quitting and utilise cessation services.

The clinical trial aims to test the effectiveness of opt-out referral, with or without behavioural economic-based mobile messaging, compared to opt-in referral, in promoting smoking cessation. The trial will be nested within the 15th "Quit to Win" Smoke-free Community Campaign organised by the Hong Kong Council on Smoking and Health.

Study Type

Interventional

Enrollment (Estimated)

1017

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Community Sites
        • Contact:
          • Tzu Tsun Luk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Hong Kong residents aged 18 years or above
  2. Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
  3. Exhaled carbon monoxide level ≥4 parts per million or a positive salivary cotinine test
  4. Able to communicate in and read Chinese
  5. Own a smartphone with a mobile instant messaging app installed

Exclusion Criteria:

  • Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Opt-out+ group
Brief cessation advice + Opt-out active referral + behavioural economics mobile messaging

Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model:

A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again

Participants will be automatically referred to a smoking cessation service upon joining the trial, unless they choose to opt out. Contacts of participants will be delivered to a service provider of their choice or based on their living district and preferred treatment modality
Participants will receive behavioural economics-informed messages via mobile instant messaging for 3 months
Experimental: Opt-out group
Brief cessation advice + Opt-out active referral

Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model:

A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again

Participants will be automatically referred to a smoking cessation service upon joining the trial, unless they choose to opt out. Contacts of participants will be delivered to a service provider of their choice or based on their living district and preferred treatment modality
Active Comparator: Opt-in group
Brief cessation advice + Opt-in active referral

Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model:

A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again

Participants will be offered a referral to a smoking cessation service. Contacts of participants who opt-in will be delivered to a service provider of their choice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemically validated tobacco abstinence
Time Frame: 6 months after randomisation
Verified by an exhaled carbon monoxide level of <4 parts per million and a negative salivary cotinine test
6 months after randomisation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemically validated tobacco abstinence
Time Frame: 3 months after randomisation
Verified by an exhaled carbon monoxide level of <4 parts per million and a negative salivary cotinine test
3 months after randomisation
Self-reported 7-day point-prevalence tobacco abstinence
Time Frame: 3 months after randomisation
Tobacco abstinence in the past 7 days
3 months after randomisation
Self-reported 7-day point-prevalence tobacco abstinence
Time Frame: 6 months after randomisation
Tobacco abstinence in the past 7 days
6 months after randomisation
Self-reported 24-hour quit attempt
Time Frame: 3 months after randomisation
Tobacco abstinence for at least 24 hours
3 months after randomisation
Self-reported 24-hour quit attempt
Time Frame: 6 months after randomisation
Tobacco abstinence for at least 24 hours
6 months after randomisation
Self-reported use of smoking cessation service
Time Frame: 3 months after randomisation
Use of any smoking cessation service during the follow-up period
3 months after randomisation
Self-reported use of smoking cessation service
Time Frame: 6 months after randomisation
Use of any smoking cessation service during the follow-up period
6 months after randomisation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported reduction of tobacco consumption
Time Frame: 3 months after randomisation
Smoking reduction by at least half of the baseline daily number of cigarettes
3 months after randomisation
Self-reported reduction of tobacco consumption
Time Frame: 6 months after randomisation
Smoking reduction by at least half of the baseline daily number of cigarettes
6 months after randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tzu Tsun Luk, PhD, RN, The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2024

Primary Completion (Estimated)

April 30, 2025

Study Completion (Estimated)

May 31, 2025

Study Registration Dates

First Submitted

June 4, 2024

First Submitted That Met QC Criteria

June 4, 2024

First Posted (Actual)

June 10, 2024

Study Record Updates

Last Update Posted (Actual)

July 19, 2024

Last Update Submitted That Met QC Criteria

July 17, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • QTW2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Smoking

Clinical Trials on Brief cessation advice

Subscribe